Key Developments For Vision Sciences Inc
Vision Sciences Inc (VSCI.O) (Consolidated Issue listed on NASDAQ Capital Market)
Vision-Sciences, Inc. Announces Resignation Of President, Chief Executive Officer; Appoints Interim Chief Executive Officer
Vision-Sciences, Inc. announced the appointment of Mr. Warren Bielke, a director, as Interim Chief Executive Officer. Mr. Bielke replaces Mr. Ron Hadani who resigned as President, Chief Executive Officer and as a member of the Board of Directors of Vision-Sciences, effective immediately. Mr. Hadani resigned for personal reasons.
Vision-Sciences, Inc. Announces Resignation Of Yoav M. Cohen As CFO-Form 8K
Vision-Sciences, Inc. announced in its form 8K that the Company entered into an employment letter with Katherine L. Wolf, pursuant to which Ms. Wolf was named the Company’s Executive-Vice President, Development and Chief Financial Officer (CFO), effective September 16, 2008. Ms. Wolf will succeed Yoav M. Cohen, who will be resigning to return to NYC Advisors, LLC, a financial advisory firm.
Vision-Sciences, Inc. Announces New Chief Financial Officer
Vision-Sciences, Inc. announced that Katherine Wolf has been named as the Company's Executive Vice-President, Corporate Development and Chief Financial Officer, effective September 16,2008.
Vision-Sciences, Inc. Receives CE Clearance And Health Canada Approval To Market Its Video-Based Advanced Endoscopy Lines
Vision-Sciences, Inc. announced that it received approval from Underwriters Laboratories Inc. to affix the CE Mark to its new line of advanced digital, video-based flexible endoscopes, which come with an integrated 'built-in' light source, eliminating the need for a separate camera head, light cable and optical coupler. Vision-Sciences also announced Health Canada approval for these scopes. With Health Canada's approval, and the approval of applicable technical files and updated EC Certificates, Vision-Sciences is now permitted to distribute and sell its scopes throughout all EU countries and Canada.
Vision-Sciences, Inc. Receives FDA Clearance For Cystoscope Device
Vision-Sciences, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new advanced digital, video based flexible Cystoscope, which is used in conjunction with an integrated built in light source, eliminating the need for a separate camera head, light guide cable and optical coupler.
